UGDH and osteoarthritis: For the “Erasers”, compounds such as the p300 inhibitor A485 can inhibit UDP-glucose dehydrogenase (UGDH) lactylation in vitro and in vivo, rescuing chondrocyte extracellular matrix degradation and delaying the progression of osteoarthritis (OA).